Exchange: NASDAQ·Updated 07:29 PM EDT
DYAI logo

DYAI Dyadic International Inc., DE

$0.4967
$0.0235
(4.48%)
Today
Closed $0.5007
$0.004
(0.80%)
After Hours
Reported EarningsAug 12
Mkt Cap$21M
Vol309,224.00

About DYAI

Dyadic International, Inc. engages in developing a gene expression platform for producing commercial quantities of industrial enzymes and other proteins. It focuses on further improving and applying its proprietary C1 technology, which is used in the discovery, development, and manufacture of biologic medicines and vaccines. The company was founded by Mark A. Emalfarb in 1979 and is headquartered in Jupiter, FL.
50

Neutral Sentiment

How do you feel about DYAI?

Advertisement|Remove ads.